Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

86
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
86
Skin Cancer01:30

Skin Cancer

4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

14
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
14
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.

Clinical advances in hematology & oncology : H&O·2026
Same author

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus.

Pediatric blood & cancer·2026
Same author

Treatment of Vascular Anomalies With Sirolimus: Characterizing Practice Patterns of US Specialist Clinicians.

Pediatric blood & cancer·2026
Same author

Guidance adherence in the evaluation and management of hepatic hemangiomas in infants and children.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Impact of anticoagulation on quality of life in patients with slow-flow vascular malformations.

Blood vessels, thrombosis & hemostasis·2025
Same author

Cutaneous adverse events associated with mitogen activated protein kinase inhibitors for the treatment of vascular anomalies: A dual-center retrospective study.

Journal of the American Academy of Dermatology·2025

相关实验视频

Updated: Jul 15, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.7K

在管理婴儿血瘤的实践变化.

Thomas W McLean1, Alexandra J Borst2, Adrienne M Hammill3

  • 1Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology and the Divisions of Pediatric Hematology/Oncology, Wake Forest University School of Medicine, Winston-Salem.

Journal of pediatric hematology/oncology
|September 26, 2023
PubMed
概括

婴儿血管瘤 (IH) 的管理在临床医生之间有很大差异. 这项研究突出了IH治疗方法的不一致性,强调需要更新,基于证据的指导方针,以确保最佳的患者护理.

更多相关视频

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.4K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.9K

相关实验视频

Last Updated: Jul 15, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.7K
A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

5.4K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

2.9K

科学领域:

  • 儿科皮肤病学 儿科皮肤病学
  • 血管异常 血管异常
  • 临床实践的变化 临床实践的变化

背景情况:

  • 婴儿血瘤 (IH) 是最常见的儿科瘤.
  • 贝塔抑制剂,特别是普拉诺洛尔,是IH的标准治疗方法.
  • 现有的指导方针并不完全解决所有临床管理问题.

研究的目的:

  • 为了记录目前的临床实践在IH管理的变化.
  • 确定需要进一步研究和指导方针开发的领域.
  • 评估提供者对IH治疗的方法.

主要方法:

  • 一个基于互联网的调查分发给治疗IH的临床医生.
  • 提出了假设的临床病例和管理场景.
  • 收集了关于治疗策略,剂量,持续时间和随访的数据.

主要成果:

  • 在患者选择治疗,最佳剂量和普拉诺洛尔治疗持续时间方面存在显著差异.
  • 实践在患者监测,需要额外的治疗和停止使用普拉诺洛尔方面有所不同.
  • 大多数受访者在头部和部IH治疗中使用通用普罗普兰诺洛尔 (2mg/kg/d),直到大约1岁.

结论:

  • 在临床医生中,婴儿血管瘤管理的广泛实践差异仍然存在.
  • 需要进一步的研究来解决这些不一致性.
  • 制定最新的,基于证据的指导方针对于标准化的内脏卫生保健至关重要.